Cargando…
Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
BACKGROUND: Sickle cell disease is highly prevalent in sub-Saharan Africa, where it accounts for substantial morbidity and mortality. Newborn screening is paramount for early diagnosis and enrolment of affected children into a comprehensive care programme. Up to now, this strategy has been greatly i...
Autores principales: | Nnodu, Obiageli E, Sopekan, Alayo, Nnebe-Agumadu, Uche, Ohiaeri, Chinatu, Adeniran, Adeyemi, Shedul, Grace, Isa, Hezekiah A, Owolabi, Olumide, Chianumba, Reuben I, Tanko, Yohanna, Iyobosa, Juliet H, Adekile, Adekunle D, Olapade, Olufunmilayo I, Piel, Frédéric B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322555/ https://www.ncbi.nlm.nih.gov/pubmed/32589979 http://dx.doi.org/10.1016/S2352-3026(20)30143-5 |
Ejemplares similares
-
Contribution of malaria and sickle cell disease to anaemia among children aged 6–59 months in Nigeria: a cross-sectional study using data from the 2018 Demographic and Health Survey
por: Chao, Dennis L, et al.
Publicado: (2022) -
Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders
por: Isa, Hezekiah, et al.
Publicado: (2023) -
Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria
por: Chianumba, Reuben Ikechukwu, et al.
Publicado: (2022) -
Determinants of hydroxyurea use among doctors, nurses and sickle cell
disease patients in Nigeria
por: Isa, Hezekiah Alkali, et al.
Publicado: (2022) -
HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges
por: Nnodu, Obiageli, et al.
Publicado: (2019)